Market Research Future (MRFR) expects the non-invasive prenatal testing (NIPT) market to touch USD 8,217.53 MN by 2027. Meanwhile, the market expansion rate is projected to be around 12.8% from 2020 to 2027 (review period).
Primary Boosters and Restraints
Escalation in cases of chromosomal abnormalities along with the rising use of NIPT devices in a variety of applications could help generate significant revenues in the coming years. Innovations in non-invasive prenatal tests to facilitate higher functions, better bioinformatics analysis and improved chemistry should also spur the business growth. Improvements in reimbursement policies with respect to low-risk and average pregnancies also enhances the market size. For instance, in December 2020, Natera extended its coverage from the biggest U.S. Health Plan named Aetna with respect to its NIPT, covering every type of pregnancy.
Get Request Free Sample @ https://www.marketresearchfuture.com/sample_request/8371
NIPT is increasingly being used among patients above the age of 35 experiencing high-risk pregnancies. Mounting awareness level about chromosomal anomalies like Down syndrome also encourage women to opt for these tests.
Companies are constantly striving to develop advanced NIPT solutions to bolster their sales, in order to remain competitive in the global market. Most of these players also work on fostering their portfolios to fortify their market standings, while also launching new tests in the market.
Market Segmentation
The global NIPT market has been segmented based on product type, techniques, application, and end user.
The market, based on product type, has been divided into devices, consumables, and others. The devices segment has been further classified as ultrasound devices, polymerase chain reaction instruments, microarrays, sequencing systems, and others. The devices are likely to hold the maximum market share in the global NIPT market. Consumables are further segmented into assay kits & reagents, disposables, and others.
The global NIPT market on the basis of techniques has been segregated into biochemical screening tests and ultrasound detection.
On the basis of application, the global non-invasive prenatal testing market is segmented into trisomy microdeletion syndrome and others.
The end user segment of the market consists of diagnostic laboratories, hospitals, and research institutes. The diagnostic laboratories segment is expected to hold the largest share of the market as these centers are primary locations for patients receiving non-invasive prenatal testing.
Regional Status
The market has been divided, by region, into the Americas, Europe, Asia-Pacific, and the Middle East & Africa.
The Americas is anticipated to hold the largest market share owing to the increasing awareness about advanced NIPT procedures. The non-invasive prenatal testing market is divided into the Americas has further been branched into North America and Latin America, with the North American market being divided into the US and Canada.
The non-invasive prenatal testing market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. Asia-Pacific is anticipated to hold the largest market share owing to the increasing number of increasing population and rising adoption of technological advancements in developing regions. The European NIPT market has been categorized as Western Europe and Eastern Europe. The Western European market has further been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe. The non-invasive testing market in the Middle East & Africa has been divided into the Middle East and Africa.
Prominent Contenders
General Electric Company [GE Healthcare] (US), Perkinelmer, Inc. (US), Illumina, Inc. (US), Beijing Genomics Institute (China), Thermo Fisher Scientific, Inc. (US), Tarsa Therapeutics Inc. (US), PhytoHealth Corporation (Taiwan), Laboratory Corporation of America Holdings (US), Hoffman-La Roche Ltd. (Switzerland), Yourgene Health (UK), Centogene Holding AG [CENTOGENE AG] (Germany), Natera, Inc. (US), Agilent Technologies, Inc. (US), are some of the top companies in the non-invasive prenatal testing industry.
Latest Updates
January 2021
Variantyx, a renowned company known for its excellence in highly complex hereditary disorder testing, has released its latest Genomic Unity Prenatal Analysis test. This non-invasive prenatal testing helps detect any structural anomaly related to the fetus, which can either be mild or extreme. The test helps achieve the molecular diagnosis to ensure prenatal as well as perinatal management.
Table of Contents
1. REPORT PROLOGUE
2. MARKET INTRODUCTION
2.1. Definition
2.2. Scope of the Study
2.2.1. Research Objective
2.2.2. Assumptions
2.2.3. Limitations
3. RESEARCH METHODOLOGY
3.1. Overview
3.2. Primary Research
3.3. Secondary Research
3.4. Market Size Estimation
4. MARKET DYNAMICS
4.1. Overview
4.2. Drivers
4.3. Restraints
4.4. Opportunities
5. MARKET FACTOR ANALYSIS
5.1. Porter’s Five Forces Analysis
5.1.1. Bargaining Power of Suppliers
5.1.2. Bargaining Power of Buyers
5.1.3. Threat of New Entrants
5.1.4. Threat of Substitutes
5.1.5. Intensity of Rivalry
5.2. Value Chain Analysis
Browse Complete Report With Consider Covid19 Impact @ https://www.marketresearchfuture.com/reports/non-invasive-prenatal-testing-market-8371
Related reports link:-
Fetal and Neonatal Care Equipment Market
Medical Cannabis Market
Laboratory Equipment Market
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research Consulting Services.
MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.
In order to stay updated with technology and work process of the industry, MRFR often plans conducts meet with the industry experts and industrial visits for its research analyst members.
Contact:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
Maharashtra, India
+1 646 845 9312
0 Comments